Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

被引:0
|
作者
M Tanioka
C Shimizu
K Yonemori
K Yoshimura
K Tamura
T Kouno
M Ando
N Katsumata
H Tsuda
T Kinoshita
Y Fujiwara
机构
[1] National Cancer Center Hospital,Breast and Medical Oncology Division
[2] Hyogo Cancer Center,Medical Oncology Division
[3] Translational Research Center,Department of Clinical Trial Design and Management
[4] Kyoto University Hospital,Division of Diagnostic Pathology
[5] National Cancer Center Hospital,Division of Breast Surgery
[6] National Cancer Center Hospital,undefined
来源
British Journal of Cancer | 2010年 / 103卷
关键词
breast cancer; pathologic complete response; neoadjuvant chemotherapy; predictive factor; trastuzumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:297 / 302
页数:5
相关论文
共 50 条
  • [1] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [2] Breast cancer recurrence and predictors for recurrence despite pathologic complete response following neoadjuvant chemotherapy
    Borremans, K.
    Berteloot, P.
    Van Nieuwenhuysen, E.
    Han, S.
    Hoste, G.
    Wildiers, H.
    Punie, K.
    Smeets, A.
    Nevelsteen, I.
    Floris, G.
    Van Ongeval, C.
    Keupers, M.
    Prevos, R.
    Van Limbergen, E.
    Menten, J.
    Weltens, C.
    Janssen, H.
    Vergote, I.
    Neven, P.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [3] Survival and recurrence of breast cancer patients with pathologic complete response after neoadjuvant chemotherapy.
    Lee, Young Joo
    Ahn, Sei-Hyun
    Sohn, Byung Ho
    Lee, Jong Won
    Chung, Il Yong
    Ko, Beom Seok
    Kim, Hee Jeong
    Kim, Jisun
    Lee, Sae Byul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Predictors of recurrence among patients with breast cancer who achieved a pathologic complete response (pCR) after neoadjuvant systemic chemotherapy
    Chavez-MacGregor, M.
    Lei, X.
    Litton, J. K.
    Melhem, A.
    Mittendorf, E. A.
    Meric-Bernstam, F.
    Sahin, A. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Predictors of Pathologic Complete Response in Axillary Nodes After Neoadjuvant Chemotherapy for Breast Cancer
    Ahn, Soojin
    Romeiser, Jamie
    O'Hea, Brian
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 24 - 25
  • [6] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Mueller, Carolin
    Schmidt, Gilda
    Juhasz-Boess, Ingolf
    Jung, Lisa
    Huwer, Sarah
    Solomayer, Erich-Franz
    Juhasz-Boess, Stephanie
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1065 - 1071
  • [7] Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
    Carolin Müller
    Gilda Schmidt
    Ingolf Juhasz-Böss
    Lisa Jung
    Sarah Huwer
    Erich-Franz Solomayer
    Stephanie Juhasz-Böss
    [J]. Archives of Gynecology and Obstetrics, 2021, 304 : 1065 - 1071
  • [8] Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy
    Xie, Li-Yun
    Wang, Kun
    Chen, Hai-Lu
    Shi, Yan-Xia
    Zhang, Yuan-Qi
    Lin, Hao-Yu
    Liang, Yuan-Ke
    Xiao, Ying-Sheng
    Wu, Zhi-Yong
    Yuan, Zhong-Yu
    Qiu, Si-Qi
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Predictors of Locoregional Recurrence After Failure to Achieve Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Gabani, Prashant
    Merfeld, Emily
    Srivastava, Amar J.
    Weiner, Ashley A.
    Ochoa, Laura L.
    Mullen, Dan
    Thomas, Maria A.
    Margenthaler, Julie A.
    Cyr, Amy E.
    Peterson, Lindsay L.
    Naughton, Michael J.
    Ma, Cynthia
    Zoberi, Lmran
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (04): : 348 - 356
  • [10] Clinical and pathologic predictors of complete pathologic response to neoadjuvant docetaxel/anthracycline chemotherapy in breast cancer patients.
    Coplin, M
    Naughton, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 85S - 85S